Ascendis Pharma A/S (ASND) Major Shareholders
Ascendis Pharma A/S shareholders at a glance
The largest holder of Ascendis Pharma A/S stock is RA Capital Management LP, with 10.3 million shares (16.48% of the company), worth about $2.70 billion as of September 25, 2026. The 10 largest holders together own 68.2%.
In Q2 2026, 11 institutional holdings reports listed 543,000 shares worth $145.00 million.
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026).
Ascendis Pharma A/S
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Ascendis Pharma A/S shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| RA Capital Management LP | 10.3 million | 16.48% | $2.7B |
| T. Rowe Price Investment Management, Inc. | 6.8 million | 10.83% | $1.8B |
| Avoro Capital Advisor LLC | 5.1 million | 8.19% | $1.3B |
| Westfield Capital Management Co. LP | 4.8 million | 7.69% | $1.3B |
| Janus Henderson Investors US LLC | 3.6 million | 5.85% | $960.0M |
| Fidelity Management & Research Co. LLC | 3.5 million | 5.68% | $933.0M |
| Artisan Partners Holdings LP | 2.6 million | 4.22% | $693.0M |
| Capital Research & Management Co. (International Investors) | 2.0 million | 3.19% | $523.0M |
| BlackRock Advisors LLC | 1.9 million | 3.09% | $507.0M |
| MFS Investment Management Canada Ltd. | 1.9 million | 3.01% | $493.0M |
As of September 25, 2026.
Ascendis Pharma A/S institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 11 | 543,000 | $145.0M |
| Q1 2026 | 293 | 54.7 million | $12.5B |
| Q4 2025 | 335 | 65.8 million | $14.0B |
| Q3 2025 | 306 | 68.8 million | $12.7B |
| Q2 2025 | 266 | 63.3 million | $10.9B |
| Q1 2025 | 262 | 65.6 million | $10.2B |
| Q4 2024 | 229 | 64.2 million | $8.8B |
| Q3 2024 | 242 | 63.1 million | $9.3B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Questions and answers
Who owns the most Ascendis Pharma A/S stock?
RA Capital Management LP, with 16.48% of the company (as of September 25, 2026). Next: T. Rowe Price Investment Management, Inc. (10.83%) and Avoro Capital Advisor LLC (8.19%).
How many institutions own Ascendis Pharma A/S stock?
11 institutional holdings reports listed Ascendis Pharma A/S shares in Q2 2026, 543,000 shares in all worth $145.00 million.
